Furthermore, compound 7k exhibited selective cytotoxicity against colorectal cancer cells and induced apoptosis via p53/p21/caspase 3 signaling, thereby leading to in vivo antitumor activity when orally administered as a single agent. This evidence concerns the gene CASP3 and colorectal cancer.